A pharmaceutical composition comprising the combination of an antiarthritic agent and an interleukin-1 inhibiting agent useful for the control and treatment of osteoarthritis and related diseases.
MARIA ELENA GARCÍA ARMENTA,VICTOR GUILLERMO ÁLVAREZ OCHOA,JOSEFINA SANTOS MURILLO
申请号：
BRPI0817564
公开号：
BRPI0817564A2
申请日:
2008.09.10
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising the synergic combination of an antiarthritic agent know as chondroitin sulphate and an interleukin-1 inhibiting agent know as diacerein, as well as pharmaceutically acceptable excipients, which are formulated in a single dosage unit to be administered orally. The composition, which is used to control and treat osteoarthritis and related diseases, provides an improved therapeutic effect and faster pharmacological action in less time, as well as reducing pain and inflammation and altering the course of the structural articular cartilage disease, with reduced risk of severe complications and/or side effects.
